Clozapine In Severe Conduct Disorder.

dc.creatorTeixeira, Eduardo H
dc.creatorCeleri, Eloisa V
dc.creatorJacintho, Antonio C A
dc.creatorDalgalarrondo, Paulo
dc.date2013-Feb
dc.date2015-11-27T13:31:16Z
dc.date2015-11-27T13:31:16Z
dc.date.accessioned2018-03-29T01:17:05Z
dc.date.available2018-03-29T01:17:05Z
dc.identifierJournal Of Child And Adolescent Psychopharmacology. v. 23, n. 1, p. 44-8, 2013-Feb.
dc.identifier1557-8992
dc.identifier10.1089/cap.2011.0148
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/23347126
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/200452
dc.identifier23347126
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1300685
dc.descriptionAn open, naturalistic observational study design was used, in which a sample of seven boys between 10 and 14 years of age was assessed over 26 weeks. The subjects were all diagnosed with conduct disorder (CD) and exhibited high levels of aggression that were refractory to psychosocial approaches (parent counseling, school counseling, and psychotherapy) and to more than three pharmacological treatments. Levels of aggression, side effects, and hematological parameters were evaluated weekly. Clinical response was evaluated using the standardized instruments Clinical Global Impressions (CGI) and Child Behavior Check List (CBCL) 6-18 before starting medication and after 26 weeks. We observed good tolerability of clozapine in doses from 100 to 600 mg/day with no significant side effects or hematological changes. The CGI and CBCL 6-18 scales indicated that clozapine led to a marked control of symptoms.
dc.description23
dc.description44-8
dc.languageeng
dc.relationJournal Of Child And Adolescent Psychopharmacology
dc.relationJ Child Adolesc Psychopharmacol
dc.rightsfechado
dc.rights
dc.sourcePubMed
dc.subjectAdolescent
dc.subjectAdolescent Behavior
dc.subjectAggression
dc.subjectAntipsychotic Agents
dc.subjectBlood Cell Count
dc.subjectChild
dc.subjectChild Behavior
dc.subjectClozapine
dc.subjectConduct Disorder
dc.subjectHumans
dc.subjectMale
dc.titleClozapine In Severe Conduct Disorder.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución